Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ganciclovir outshines aciclovir in oral prophylaxis of CMV disease

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Ganciclovir outshines aciclovir in oral prophylaxis of CMV disease. Pharmacoecon. Outcomes News 174, 6 (1998). https://doi.org/10.1007/BF03285666

    Download citation

    Keywords

    • Acyclovir
    • Ganciclovir
    • Pancreas Transplant
    • Total Hospital Cost
    • Oral Ganciclovir